Jianping Dou
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in ⓘ
- Surgery 23
- Thyroid and Parathyroid Surgery 8
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Hepatology 18
- Hepatocellular Carcinoma Treatment and Prognosis 15
- Co-authors
- Ping Liang (48 shared papers)Jie Yu (42 shared papers)Xiaoling Yu (22 shared papers)Xianwei Meng (6 shared papers)Fangyi Liu (26 shared papers)Longfei Tan (5 shared papers)Zhigang Cheng (22 shared papers)Zhiyu Han (21 shared papers)
- Journals
- International Journal of Hyperthermia (9 papers)Ultrasound in Medicine & Biology (4 papers)Radiology (3 papers)ACS Nano (3 papers)Abdominal Radiology (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Jianping Dou
58 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 102
- Hepatology 201
- Biomaterials 207
- Nephrology 92
- Biomedical Engineering 448
- Immunology 131
Countries citing papers authored by Jianping Dou
This map shows the geographic impact of Jianping Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Dou more than expected).
Fields of papers citing papers by Jianping Dou
This network shows the impact of papers produced by Jianping Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Dou. The network helps show where Jianping Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianping Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 107 | |
| 2 | 2016 | 99 | |
| 3 | 2013 | 90 | |
| 4 | 2019 | 81 | |
| 5 | 2021 | 79 | |
| 6 | 2020 | 67 | |
| 7 | 2016 | 53 | |
| 8 | 2022 | 46 | |
| 9 | 2023 | 42 | |
| 10 | 2019 | 41 | |
| 11 | 2016 | 38 | |
| 12 | 2017 | 27 | |
| 13 | 2022 | 27 | |
| 14 | 2020 | 25 | |
| 15 | 2018 | 23 | |
| 16 | 2019 | 22 | |
| 17 | 2023 | 21 | |
| 18 | 2021 | 21 | |
| 19 | 2019 | 21 | |
| 20 | 2017 | 19 |
About Jianping Dou
Jianping Dou is a scholar working on Surgery, Hepatology, Biomedical Engineering, Epidemiology and Biomaterials, having authored 61 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Nanoplatforms for cancer theranostics (10 papers), Thyroid and Parathyroid Surgery (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Thyroid Cancer Diagnosis and Treatment (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Ultrasound and Hyperthermia Applications (6 papers). The work is most often cited by research in Hepatology (201 citations), Biomaterials (207 citations), Nephrology (92 citations), Biomedical Engineering (448 citations) and Immunology (131 citations). Jianping Dou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ping Liang, Jie Yu, Xiaoling Yu, Xianwei Meng, Fangyi Liu, Longfei Tan, Zhigang Cheng, Zhiyu Han, Tianlong Liu and Changhui Fu. Their work appears in journals such as International Journal of Hyperthermia, Ultrasound in Medicine & Biology, Radiology, ACS Nano and Abdominal Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.